People: VirtualScopics Inc (VSCP.O)

VSCP.O on Consolidated Issue listed on NASDAQ Capital Market

4.10USD
22 Jul 2014
Price Change (% chg)

$0.01 (+0.15%)
Prev Close
$4.09
Open
$4.10
Day's High
$4.12
Day's Low
$4.07
Volume
2,234
Avg. Vol
6,564
52-wk High
$6.90
52-wk Low
$2.93

Search Stocks

Summary

Name Age Since Current Position

Charles Phelps

71 2014 Independent Chairman of the Board

Eric Converse

47 2013 Interim President and Chief Executive Officer, Director

Jim Groff

43 2013 Acting Chief Financial Officer

Daniel Kerpelman

54 2008 Independent Director

Norman Mintz

78 2007 Independent Director

David Rubin

48 2012 Independent Director

Terence Walts

62 2005 Independent Director

Tim Ryan

IR Contact

Biographies

Name Description

Charles Phelps

Dr. Charles E. Phelps, Ph.D., serves as an Independent Chairman of the Board of VirtualScopics Inc., since June 20, 2014. Dr. Phelps has served as a director of the company since December 2005. Dr. Phelps, University Professor and Provost Emeritus at the University of Rochester, retired from the position of provost of the University of Rochester in July 2007, a position he had held since 1994. Prior to that, Dr. Phelps was the chair of the Department of Community and Preventive Medicine—now the Department of Public Health Sciences--in the University of Rochester’s School of Medicine and Dentistry, and Director of the University’s Public Policy Analysis Program. Before joining the University of Rochester in 1984, Dr. Phelps was Senior Staff Economist at the RAND Corporation. Dr. Phelps has a bachelor’s degree in mathematics from Pomona College, an MBA in hospital administration from the University of Chicago, and a Ph.D. in business economics from the University of Chicago. Dr. Phelps was elected to the Institute of Medicine of the National Academy of Sciences in 1991, and in the same year, as Fellow of the National Bureau of Economic Research. He is widely regarded as a leading figure in the field of health economics. He has also testified before the U.S. Congress on three occasions regarding reform of U.S. patent and other intellectual property law on behalf of the Association of American Universities (AAU) and the American Association of Medical Colleges (AAMC). Dr. Phelps has previously served on the Board of Directors of Reflex Security, Inc.; the Center for Research Libraries; and the Council for Library and Information Resources, including Board Chair for two years.

Eric Converse

Mr. Eric Converse is Interim President and Chief Executive Officer, Director of the Company. Mr. Converse has served as a director of the Company since August 13, 2013, and is a member of the Strategic Planning Committee of the Board of Directors. Prior to joining the Company, Mr. Converse has spent over ten years at Nedamco Capital, where he was most recently its Managing Director. He has over 20 years of hands-on management experience working with early-stage companies. He represented Nedamco Capital’s interest as CEO of Oblicore, which was subsequently acquired by CA Technologies. Prior to joining Nedamco Capital, Mr. Converse was CEO of Oneswoop.com, which was acquired by Norwich Union Consumer Products (Aviva). Earlier in his career, Mr. Converse worked for Nedamco North America Corporation, a US-based global technology development company, where he led the development of new markets (primarily India and China) and played an active role in its successful sale. Eric received his B.S. degree from Michigan State University and attended Erasmus University in Rotterdam, the Netherlands.

Jim Groff

Mr. Jim Groff has been appointed as Acting Chief Financial Officer of VirtualScopics, Inc., effective August 31, 2013. Mr. Groff has served as the Controller of the Company since February 2013 and previously as its Accounting Manager since January 2006. His responsibilities included the preparation and oversight of internal and external reporting including public filings and the review and implementation of the Company’s financial controls.

Daniel Kerpelman

Mr. Daniel I. Kerpelman serves as an Independent Director of VirtualScopics Inc., since May 2008. He is the President and Chief Executive Officer of Bio-Optronics, Inc., a healthcare workflow software company based in Rochester, New York and Nyon, Switzerland. Previously, he was Chief Executive Officer of Société Generale de Surveillance, SA in Geneva, Switzerland. From June 2002 through March 2005, Mr. Kerpelman was Senior Vice President of Eastman Kodak and President of its Health Imaging Group, which focused on medical and dental imaging equipment, consumables and information technology. He spent most of his earlier career with GE Healthcare. Mr. Kerpelman is an engineer with degrees from the CNAM (France), University of Maryland and Rensselaer Polytechnic Institute and holds a MBA from Northwestern University. He serves on the Boards of Directors of Cotecna SA and the University of Rochester Medical Center.

Norman Mintz

Dr. Norman N. Mintz, Ph.D., serves as an Independent Director of VirtualScopics Inc., since June 5, 2007. Since 1990, Dr. Mintz has served as a Managing Director for Loeb Partners Corporation. Dr. Mintz has a Ph.D. in Finance and Economics from New York University, and has previously served as Professor of Finance at Syracuse University and Professor of Economics at Columbia University. Prior to 1990, he served as Executive Vice President of Columbia University. Dr. Mintz serves as a director of Intersections, Inc. (Nasdaq: INTX:US) as well as several private companies.

David Rubin

Dr. David Rubin, Ph.D., serves as an Independent Director of VirtualScopics Inc., since April 3, 2012. Dr. Rubin has been an investment principal in Merck's Global Healthcare Innovation Fund since September 2010. Dr. Rubin joined Merck in 2007 as Director of Franchise and Portfolio Management. Previously, Dr. Rubin was CEO and President, from 2000 through 2005, and CSO and SVP of Product Management, from 2006 through 2007, of Cognia Corporation, a bioinformatics company supporting biopharmaceutical research and development. Previously, Dr. Rubin was at The Wilkerson Group/IBM Global Services in a Strategic Management position, servicing a broad range of health care companies. Dr. Rubin holds a Ph.D. from Temple University in Molecular Biology and a B.A. from SUNY Binghamton in Biology. He was an National Institutes of Health and American Cancer Society Post-Doctoral fellow at Harvard Medical School, where he worked on the Ubiquitin Proteasome Pathway.

Terence Walts

Mr. Terence A. Walts serves as an Independent Director of VirtualScopics Inc., since December 8, 2005. Mr. Walts is President, CEO and Director of Transfusion & Transplantation Technologies LLC (“3Ti”), a medical device/diagnostics company developing next generation automated blood analyzer technology and associated consumables for the pre-transfusion/immunohematology market. Prior to joining 3Ti, Mr. Walts served for three years and until late 2005 as President, CEO of Refocus Group, Inc., (OTCBB: RFCS) an eye care company developing a surgical procedure for presbyopia and glaucoma. Prior to that position, Mr. Walts acted as a consultant to medical startup companies and held positions with, among others, Oncose, Inc., an in-vitro diagnostics company, PointDx, a virtual colonoscopy and structural radiology reporting software company, and Medjet, Inc., an early stage medical devices company. He served as Senior Vice President of CIBA Vision (Novartis), a diversified eye care company from 1988 to 1998. He holds a BS in Marketing from Indiana University and a MBA from the University of Notre Dame.

Tim Ryan

Basic Compensation

Name Fiscal Year Total

Charles Phelps

--

Eric Converse

81,512

Jim Groff

144,756

Daniel Kerpelman

--

Norman Mintz

--

David Rubin

--

Terence Walts

--

Tim Ryan

--
As Of 30 Dec 2013

Options Compensation

Search Stocks